Epigene Labs and Institut Curie announce a partnership

Majycc eSanté Invest is proud to annonce that Epigene Labs and Institut Curie just signed a partnership to improve ovarian cancer treatment. This promising collaboration will draw on Institut Curie's oncological expertise combined with Epigene Labs' innovative data-driven technology.

More information : https://techtransfer.institut-curie.org/news/innovation/epigene-labs-institut-curie-announce-partnership-improve-ovarian-cancer-treatment